Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Professional Identity and Professionalism in Nursing Education: A Call for Scholarly Attention.

Nursing education perspectives·2026
Same author

A clinical review of cervical cancer.

Nursing·2026
Same author

Defining Who We Are: The Case for a Strong Professional Identity in Nursing.

The Journal of nursing education·2026
Same author

Transforming nursing with professional identity.

Nursing management·2025
Same author

Fostering Professional Comportment Development.

Nurse educator·2025
Same author

A Bibliometric Analysis of 50 Years of Publication of Nurse Educator.

Nurse educator·2025
Same journal

Bridging disciplines through Alzheimer care: A faculty-guided summer interprofessional education experience for prelicensure nursing students.

Nursing·2026
Same journal

Improving outcomes by empowering nurses to lead change in an acute stroke unit.

Nursing·2026
Same journal

Q&A with Ken Wofford, PhD, CRNA, CHSE, FAWM, DiMM.

Nursing·2026
Same journal

Oral anticoagulant medications.

Nursing·2026
Same journal

Signs, signs, everywhere a sign!

Nursing·2026
Same journal

How does postural orthostatic tachycardia syndrome (POTS) affect pediatric patients?

Nursing·2026
See all related articles

Related Experiment Video

Updated: Jun 30, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.3K

Bladder cancer: An Update.

Richard L Pullen1

  • 1Richard Pullen is a professor at the Texas Tech University Health Sciences Center and is a member of the Nursing2024 editorial board.

Nursing
|March 22, 2024
PubMed
Summary
This summary is machine-generated.

Bladder cancer, a common urothelial cell carcinoma, arises from genetic mutations and predispositions. Understanding risk factors, symptoms, and treatments is crucial for effective patient care and education.

More Related Videos

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.5K
Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

10.3K

Related Experiment Videos

Last Updated: Jun 30, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.3K
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.5K
Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

10.3K

Area of Science:

  • Oncology
  • Urology

Background:

  • Bladder cancer is the 10th most common global cancer.
  • Urothelial cell carcinoma is its primary form.
  • Risk factors include genetic mutations and congenital predispositions.

Purpose of the Study:

  • To discuss bladder cancer risk factors.
  • To outline clinical presentation and treatment strategies.
  • To emphasize nursing support and patient education.

Main Methods:

  • Literature review of bladder cancer risk factors.
  • Analysis of clinical presentation and treatment modalities.
  • Synthesis of best practices in nursing care and patient education.

Main Results:

  • Identified key acquired genetic mutations and congenital factors.
  • Detailed common clinical signs and diagnostic approaches.
  • Summarized current treatment options and supportive care.

Conclusions:

  • Comprehensive understanding of risk factors is vital for early diagnosis.
  • Integrated treatment and patient education improve outcomes.
  • Nursing support is essential for managing bladder cancer patients.